Bo Han

11.4k total citations · 4 hit papers
123 papers, 5.4k citations indexed

About

Bo Han is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Bo Han has authored 123 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 44 papers in Pulmonary and Respiratory Medicine and 36 papers in Cancer Research. Recurrent topics in Bo Han's work include Prostate Cancer Treatment and Research (34 papers), Cancer-related molecular mechanisms research (17 papers) and RNA modifications and cancer (16 papers). Bo Han is often cited by papers focused on Prostate Cancer Treatment and Research (34 papers), Cancer-related molecular mechanisms research (17 papers) and RNA modifications and cancer (16 papers). Bo Han collaborates with scholars based in China, United States and Canada. Bo Han's co-authors include Nallasivam Palanisamy, Xuhong Cao, Xiaojun Jing, Chandan Kumar‐Sinha, Arul M. Chinnaiyan, Christopher A. Maher, Rajal B. Shah, Jindan Yu, Arul M. Chinnaiyan and Sooryanarayana Varambally and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Bo Han

117 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer

2008 833 citations Sooryanarayana Varambally, Qi Cao et al. Science profile →
Transcriptome sequencing to detect gene fusions in cancer

2009 631 citations Christopher A. Maher, Chandan Kumar‐Sinha et al. profile →
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer

2007 610 citations Scott A. Tomlins, Bharathi Laxman et al. profile →
Epidemiologic relationship between periodontitis and type 2 diabetes mellitus

2020 260 citations Yongzhi Wu, Bo Han et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bo Han China	35	3.3k	2.1k	1.8k	775	391	123	5.4k
Rosario Caltabiano Italy	38	2.1k 0.6×	1.3k 0.6×	688 0.4×	705 0.9×	252 0.6×	283	5.2k
Chung‐Ji Liu Taiwan	45	4.5k 1.3×	3.5k 1.7×	555 0.3×	1.9k 2.5×	279 0.7×	159	6.9k
Yong‐Jie Lu United Kingdom	37	2.3k 0.7×	1.3k 0.6×	1.3k 0.7×	968 1.2×	494 1.3×	143	4.3k
Nam Hoon Cho South Korea	38	1.8k 0.5×	991 0.5×	1.2k 0.7×	1.3k 1.7×	233 0.6×	223	4.9k
Nisha J. D’Silva United States	38	2.0k 0.6×	896 0.4×	602 0.3×	1.5k 2.0×	159 0.4×	109	4.6k
Reo Maruyama Japan	40	4.0k 1.2×	1.9k 0.9×	541 0.3×	1.1k 1.4×	276 0.7×	98	5.1k
Christine Gilles Belgium	40	2.8k 0.8×	2.0k 0.9×	553 0.3×	2.3k 3.0×	257 0.7×	84	5.3k
Franck Verrecchia France	40	3.4k 1.0×	816 0.4×	919 0.5×	1.0k 1.3×	441 1.1×	99	6.2k
Dale K. Kobayashi United States	25	1.1k 0.3×	1.9k 0.9×	1.5k 0.9×	1.2k 1.5×	291 0.7×	31	4.4k
Min‐Han Tan Singapore	32	1.2k 0.4×	872 0.4×	881 0.5×	971 1.3×	281 0.7×	119	3.1k

Countries citing papers authored by Bo Han

Since Specialization

Citations

This map shows the geographic impact of Bo Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Han more than expected).

Fields of papers citing papers by Bo Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Han. The network helps show where Bo Han may publish in the future.

Co-authorship network of co-authors of Bo Han

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Han. A scholar is included among the top collaborators of Bo Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Han. Bo Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Han, Bo, Jing Hu, Ping Liu, et al.. (2025). CUL4B regulates thyroid cancer differentiation and treatment sensitivity by ubiquitinating ARID1A. Translational Oncology. 56. 102389–102389.

Liu, Jian, et al.. (2024). Experimental and numerical study of the failure mechanism and stability of tunnel linings under different cavity conditions. Engineering Failure Analysis. 162. 108412–108412. 3 indexed citations

Hu, Jing, Jing Zhang, Bo Han, et al.. (2024). PLXNA1 confers enzalutamide resistance in prostate cancer via AKT signaling pathway. Neoplasia. 57. 101047–101047. 1 indexed citations

Tan, Yifei, et al.. (2024). Precise simulation of deepwater J-laying pipeline in the TDZ by refined VFIFE method. Ocean Engineering. 318. 120100–120100. 2 indexed citations

Jing, Weiqiang, Ganyu Wang, Xinyuan Li, et al.. (2024). Tumor–neutrophil cross talk orchestrates the tumor microenvironment to determine the bladder cancer progression. Proceedings of the National Academy of Sciences. 121(20). 14 indexed citations

He, Rong‐Rong, Yongzhi Wu, Xue Xiao, et al.. (2024). Ectopic thyroid follicular carcinoma in the right mandible: a case report. Gland Surgery. 13(10). 1840–1845.

Wang, Xueli, Bo Han, Feifei Sun, et al.. (2023). A trio of tumor suppressor miRNA downregulates CREB5 dependent transcription to modulate neoadjuvant hormonal therapy sensitivity. Neoplasia. 36. 100875–100875. 1 indexed citations

Sun, Feifei, Jing Hu, Zeyuan Yu, et al.. (2022). RUVBL1 promotes enzalutamide resistance of prostate tumors through the PLXNA1-CRAF-MAPK pathway. Oncogene. 41(23). 3239–3250. 18 indexed citations

Zhang, Wenbo, Feifei Sun, Jing Hu, et al.. (2020). KIF15-Mediated Stabilization of AR and AR-V7 Contributes to Enzalutamide Resistance in Prostate Cancer. Cancer Research. 81(4). 1026–1039. 57 indexed citations

10.

Ji, Jianxiong, Ran Xu, Kaikai Ding, et al.. (2019). Long Noncoding RNA SChLAP1 Forms a Growth-Promoting Complex with HNRNPL in Human Glioblastoma through Stabilization of ACTN4 and Activation of NF-κB Signaling. Clinical Cancer Research. 25(22). 6868–6881. 55 indexed citations

11.

Feng, Tingting, Feifei Sun, Qiqi Lu, et al.. (2019). TXNDC9 regulates oxidative stress-induced androgen receptor signaling to promote prostate cancer progression. Oncogene. 39(2). 356–367. 28 indexed citations

12.

Hu, Jing, Peng Su, Meng Jiao, et al.. (2018). TRPS1 Suppresses Breast Cancer Epithelial-mesenchymal Transition Program as a Negative Regulator of SUZ12. Translational Oncology. 11(2). 416–425. 26 indexed citations

13.

Wang, Lin, Guanhua Song, Xiang Zhang, et al.. (2017). PADI2-Mediated Citrullination Promotes Prostate Cancer Progression. Cancer Research. 77(21). 5755–5768. 77 indexed citations

14.

Zhang, Jing, Chengwu Shen, Lin Wang, et al.. (2014). Metformin inhibits epithelial–mesenchymal transition in prostate cancer cells: Involvement of the tumor suppressor miR30a and its target gene SOX4. Biochemical and Biophysical Research Communications. 452(3). 746–752. 72 indexed citations

15.

Niu, Na, Shuzhen Sun, Bo Han, & Yi Wang. (2013). [Relationship of ox-LDL/LOX-1 and vascular endothelial dysfunction of diet-induced obese immature rats and nicotinic acid's intervention outcomes].. PubMed. 93(42). 3388–93. 5 indexed citations

16.

Mehra, Rohit, Chandan Kumar‐Sinha, Sunita Shankar, et al.. (2011). Characterization of Bone Metastases from Rapid Autopsies of Prostate Cancer Patients. Clinical Cancer Research. 17(12). 3924–3932. 67 indexed citations

17.

Han, Bo, Lei Wang, Javed Siddiqui, et al.. (2010). ETS Gene Aberrations in Atypical Cribriform Lesions of the Prostate. The American Journal of Surgical Pathology. 34(4). 478–485. 71 indexed citations

18.

Varambally, Sooryanarayana, Qi Cao, Ram S. Mani, et al.. (2008). Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer. Science. 322(5908). 1695–1699. 833 indexed citations breakdown →

19.

Han, Bo, Rohit Mehra, Saravana M. Dhanasekaran, et al.. (2008). A Fluorescence In situ Hybridization Screen for E26 Transformation–Specific Aberrations: Identification of DDX5-ETV4 Fusion Protein in Prostate Cancer. Cancer Research. 68(18). 7629–7637. 121 indexed citations

20.

Han, Bo. (2006). Observation on the ultrastructure of caprine osteoblasts under different fluoride levels in vitro. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact